3D-printing of devices will overtake drugs
This article was originally published in Clinica
Executive Summary
As the cost of 3D printing comes down and becomes more competitively priced with existing manufacturing technologies, 3D-printed medical devices and prosthetics will become more common over the next 10 years. On the other hand, 3D-printed drugs will find it more challenging to overcome cost hurdles, thus making it more unlikely for drugs to be manufactured widely using this technology.
You may also be interested in...
Could Alcon's CyPass Trouble Be Boon For Glaukos – Or Bust For MIGS?
Minimally invasive glaucoma surgery specialist Glaukos saw its stock leap 40% in the wake of a worldwide recall by much bigger rival Alcon of its CyPass microstent.
Roche Dx' EMEA Head To Take Charge After Diggelmann Departs
Roland Diggelmann will end his decade-long career at Roche Diagnostics at the end of September. The business's head of EMEA Michael Heuer will take Diggelmann's place while the search is on for his replacement.
Nose For A Good Tech? Philips Adds Nasal Alar Pulse Oximetry To Monitoring Portfolio
Philips has added a new pulse oximetry platform to its patient monitoring portfolio, with the acquisition of Xhale Assurance.